MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients
Key facts
- Who runs it
- Health Discovery Labs
- Where
- Austin and Rochester, United StatesSee the 3 sites
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 5 May 2026
- Expected to end
- 31 Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Electrical Muscle Stimulation System
- Record updated
- 10 July 2026
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Admitted to ER or ICU within the previous 48 hours
- APACHE II score ≥ 13
- Meets the criteria for sepsis or severe sepsis
Who cannot take part
- New onset deep vein thrombosis within the previous 6-months
- Malignancy in lower limb
- Anticipated transfer to an ICU not participating in this study
- Myopathies (e.g. congenital)
- Acquired myopathies with CK levels 5-times above the upper limit of normal
- Unable to transfer from bed to chair at baseline
- Moribund
- Comfort care
- Technical obstacles - fracture, burns, amputation
- Open wound or skin abrasion at the garment application site
- Pregnancy
- Pacemaker and implantable cardioverter-defibrillator
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Where in United States
- Ascension Seton Medical Center AustinAustin, United StatesContact: Paul H. Harford, M.D.Taking people
- Dell Seton Medical Center at The University of TexasAustin, United StatesContact: Paul H. Harford, M.D.Taking people
- Mayo ClinicRochester, United StatesContact: Division of Nursing ResearchTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if a new medical device that sends electrical signals to the thigh muscles is safe and easy to use for people in the ICU (Intensive Care Unit) who are at risk of losing muscle strength. It will also explore whether this treatment can help slow down muscle weakening.
Read full original descriptionShow less
The main questions this study aims to answer are:
* Do participants develop medical problems when receiving electrical muscle stimulation in the ICU? * Is electrical muscle stimulation a practical way to help reduce muscle weakness in critically ill patients?
Researchers will compare the control group (standard of care) to the intervention group (standard of care plus 60-minute sessions of electrical muscle stimulation daily during the ICU stay) to see if the device is safe and easy to use.
Participants will:
* Receive either standard of care or standard of care plus electrical muscle stimulation of the thigh muscles * Have their muscle strength checked during the study * Complete a survey three months after ICU discharge to check on their recovery
The 2 groups in the trial
- Intervention GroupExisting treatment, for comparison
Participants will receive a daily 60-minute session of electrical muscle stimulation applied to the quadriceps for up to 7 days during ICU stay or until ICU discharge, alongside standard of care.
Treatment: Electrical Muscle Stimulation System
- Control GroupNo study treatment, for comparison
Participants will receive standard of care only
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Safety and Feasibility of the MyokinE100 System in ICU Settings to Mitigate ICU Acquired Weakness
- Criteria questions
- Built from NCT07362862, who can take part
- Record updated
- 10 July 2026